264 related articles for article (PubMed ID: 10846463)
1. [Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies].
Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
Rinsho Ketsueki; 2000 Apr; 41(4):322-8. PubMed ID: 10846463
[TBL] [Abstract][Full Text] [Related]
2. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
3. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
[TBL] [Abstract][Full Text] [Related]
4. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease.
Seth P; Alrajhi AA; Kagevi I; Chaudhary MA; Colcol E; Sahovic E; Aljurf M; Gyger M
Bone Marrow Transplant; 2002 Aug; 30(3):189-94. PubMed ID: 12189538
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
[TBL] [Abstract][Full Text] [Related]
9. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
[TBL] [Abstract][Full Text] [Related]
11. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
12. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
Kempinska A; Kwak EJ; Angel JB
Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
[TBL] [Abstract][Full Text] [Related]
14. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
17. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
Hsiao LT; Chiou TJ; Liu JH; Chu CJ; Lin YC; Chao TC; Wang WS; Yen CC; Yang MH; Tzeng CH; Chen PM
Biol Blood Marrow Transplant; 2006 Jan; 12(1):84-94. PubMed ID: 16399572
[TBL] [Abstract][Full Text] [Related]
18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
19. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
[TBL] [Abstract][Full Text] [Related]
20. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
